S&P 500

Intel Corporation: Stock Set to Rally as it Outperforms all Expectations

Amidst a lackluster stock market, Intel Corporation (NASDAQ: INTC) has been displaying strength enough to attract prospective investors. As of March 25, 2018, the Intel stock is trading 40% up year-to-date with reports of strong chip sales and improvement in the buying ratings by analytical firms. In Q4 2017, Intel posted its operating income of $5.9bn, the highest ever in over two years. Its non-GAAP EPS was $1.08, which was…


As Consumers Move toward Healthier Beverages, The Coca-Cola Company Struggles to up the Ante

As Consumers Move toward Healthier Beverages, The Coca-Cola Company Struggles to up the Ante Coca-Cola Company (NYSE: KO), the premier multinational beverages company has found itself struggling with maintaining its revenue growth. Due to ongoing re-franchising of its bottling territories, its net revenue ($7.5bn) declined by 20% in Q4 2017 and by 15% for full-year 2017.  It earned 39 cents per share for the same period. However, for Q4 it…


Time to add Johnson & Johnson to your Portfolio as Sales Projected to Grow despite Headwinds

Johnson & Johnson (NYSE: JNJ), the global healthcare behemoth, posted Q4 2017 revenue of $20.2bn (an increase of 11.5%) and 2017 full-year earnings of $76.5bn (an increase of 6.3%) on January 23, 2018. Diluted loss per share was $3.99 (adjusted diluted EPS was $1.74 which was an increase of 10.1% compared to Q4 2016); while diluted EPS for 2017 full-year was $0.47 (adjusted diluted EPS was $7.36 which was an…


Pfizer, Inc: As Earnings Improve, Pharmaceutical Giant’s Stock Shows a Positive Move

Since its inception in 1849, Pfizer, Inc. (NYSE: PFE) has introduced game-changing medicines in the market. In the past few years, the pharmaceutical giant has garnered confidence amongst shareholders and prospective investors by delivering a string of robust medicines which have contributed to its annual revenue. In Q4 2017, Pfizer’s Eliquis raked in $170m in revenue which was 46% higher than the year-ago figure, while Chantix-Champix contributed $271m in revenue…


Procter & Gamble: Poised to Race Ahead as Brand Divestitures and Cost Productivity Measures Pays Off

Procter & Gamble (NYSE: PG) stock had slid 9.92% in February 2018 after its Q2 2018 earnings release on January 23, 2018. A tantalizing problem for this Household and Consumer products giant was its performance in terms of market share. For blades and razors, the share was down to 65% from 70% in 2014 while grooming products dropped by 0.7%. As revealed in its 2017 fiscal year-end results, the overall…


Stock Markets: Dow Gains 32% Under Trump Presidency

The latest rallies in the Dow Jones Industrial Average have placed the stock market benchmark firmly above the 26,000 handle.  This break of key psychological resistance suggests that the latest moves are the strongest since the Presidency of Franklin Delano Roosevelt (FDR). The stock market closed higher in all three of the major benchmarks, further strengthening the concept that investors are responding well to the pro-growth agenda that has been promoted…


Brookfield Real Assets Offers Value in Elevated Markets

Stocks Strategies: Brookfield Real Assets (RA) Offers Value in Elevated Markets In December, Brookfield Investment Management (NYSE: RA) announced its decision to merge three legacy funds (Brookfield Mortgage Opportunity Income Fund Inc, Brookfield High Income Fund Inc., and the Brookfield Total Return Fund Inc.) These funds became the Brookfield Real Assets Income Fund (the Fund) on Dec 5th, 2016. The Fund has an annualized distribution rate of 10.3% as of March 2,…